HOME >> BIOLOGY >> NEWS
Children's Hospital Oakland scientist awarded seat on national scientific review board

Children's Hospital Oakland Research Institute's Deborah Dean, M.D., M.P.H., has accepted an invitation to play a crucial role in the National Institutes of Health (NIH) peer review process. She will serve as a regular member of the Infectious Diseases, Reproductive Health, Asthma and Pulmonary Conditions Study Section, Center for Scientific Review. "It is a great honor to serve on this most distinguished board of medical doctors and scientists, who are committed to research and curing deadly diseases," said Dr. Dean.

Study Section members review grant applications submitted to the NIH, make recommendations on these applications to the appropriate NIH national advisory council and survey the status of research in their fields of science. Members are selected for their demonstrated competence, scientific research achievements, journal publications, other significant scientific activities and honors. "Service on a study section also requires mature judgement and objectivity as well as the ability to work effectively in a group," said Toni Scarpa, M.D., Ph.D. and Director of the Center for Scientific Review, "qualities we believe Dr. Dean will bring to this important task."

Dr. Dean will be one of only 10 standing members in her study section. Each study section of the NIH peer review process consists of standing members and dozens of temporary members. Dr. Dean is an internist, whose subspecialty is infectious diseases, and also a molecular biologist. She is the pioneer of current genetic typing and comparative genomics of Chlamydia trachomatis. Her research encompasses the molecular genetics, molecular epidemiology and pathogenesis of chlamydial infections around the world. Her research is paving the way for development of the first vaccine for chlamydiae, the primary cause of preventable blindness and bacterial sexually transmitted diseases worldwide.


'"/>

Contact: Diana Yee
dyee@mail.cho.org
510-428-3120
Children's Hospital & Research Center at Oakland
15-Dec-2005


Page: 1

Related biology news :

1. Doernbecher Childrens Hospital scientist earns coveted Javits award
2. NIH selects Childrens Hospital as Center of Excellence to train future generations of scientists
3. Childrens Hospital Oakland, Calif.s new iron regulation discovery
4. Childrens Hospital researcher leads multipronged attack on infant leukemia
5. Childrens Hospital Oaklands new maternal diet study
6. Childrens Hospital and Research Center-Oakland presents a new maternal diet study
7. Childrens Hospital Boston presents at the 2006 American Academy of Pediatrics National Conference
8. Genetic research at Childrens Hospital of Pittsburgh reinforces theory of evolution
9. Childrens Hospital Boston presents at the 2006 Pediatric Academic Societies annual meeting
10. UCLA engineering and Mattel Childrens Hospital collaborate to develop childrens heart valve
11. Research center for National Childrens Study to be based in Queens

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/12/2020)... SOUTHFIELD, Mich. (PRWEB) , ... August 11, 2020 ... ... Janssen R&D subsidiary based in Princeton, NJ, have entered into license agreements with ... discovery and development. Both Roche and J&J have annual Research and Development ...
(Date:8/7/2020)... ... 2020 , ... Alucio™, a fast-growing provider of cloud-based software ... Jessica Wong have joined the company’s leadership team as Vice President of Engineering, ... development efforts for Alucio’s flagship product, Beacon, an innovative cloud-based content management and ...
(Date:8/5/2020)... , ... August 05, 2020 , ... Regenative Labs has ... new innovations, CoreText™ and ProText™, making them the first Wharton’s jelly allografts to be ... a syringe. The company’s solutions are the first Wharton’s jelly allograft product to be ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... ... July 09, 2020 , ... ... of Technology (MIT) has expanded the company’s exclusive license to include clinical ... the point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ ...
(Date:7/7/2020)... (PRWEB) , ... July 06, 2020 , ... R3 International ... program featuring up to 200 million stem cells. Depending on the patient's condition, treatment ... in the US will die having some form of Alzheimers dementia, and the incidence ...
(Date:7/1/2020)... ... June 29, 2020 , ... ... competitively procured purchasing contracts to its membership, recently named BioFit Engineered Products ... with the opportunity to purchase ergonomic seating, cafeteria tables, book trucks and carts ...
(Date:6/28/2020)... ... June 25, 2020 , ... With the COVID-19 pandemic ... drug treatment. In an effort to better understand the cellular responses to COVID-19, ... imaging dataset portraying therapeutic compound effects from over 1,600 approved and referenced molecules ...
Breaking Biology Technology:
Cached News: